Cargando…
Comparable effect with minimal morbidity of low-dose Tokyo 172 strain compared with regular dose Connaught strain as an intravesical bacillus Calmette–Guérin prophylaxis in nonmuscle invasive bladder cancer: Results of a randomized prospective comparison
AIM: The aim was to compare patients' morbidity and response of bacillus Calmette–Guérin (BCG) prophylaxis after the intravesical instillation of low-dose Tokyo 172 strain and regular dose Connaught strain in patients with nonmuscle invasive bladder cancer (NMIBC). PATIENTS AND METHODS: This wa...
Autores principales: | Inamoto, Teruo, Ubai, Takanobu, Nishida, Takeshi, Fujisue, Yutaka, Katsuoka, Yoji, Azuma, Haruhito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643329/ https://www.ncbi.nlm.nih.gov/pubmed/23662001 http://dx.doi.org/10.4103/0974-7796.106873 |
Ejemplares similares
-
809. Osteitis Caused by Bacillus Calmette-Guerin Tokyo 172 Strain in Immunocompetent Patients
por: González Saldaña, Napoleón, et al.
Publicado: (2018) -
Comparative Proteomic Profiling of Mycobacterium tuberculosis and the Thai Vaccine Strain Mycobacterium bovis Bacille Calmette–Guerin Tokyo172: Diverse Biomarker Candidates for Species Differentiation
por: Kasempimolporn, Songsri, et al.
Publicado: (2018) -
Intravesical bacillus Calmette-Guérin for bladder cancer: are all the strains equal?
por: D’Andrea, David, et al.
Publicado: (2019) -
Dose, duration and strain of bacillus Calmette–Guerin in the treatment of nonmuscle invasive bladder cancer: Meta-analysis of randomized clinical trials
por: Quan, Yongjun, et al.
Publicado: (2017) -
Tailoring the dose of Moscow strain of intravesical bacillus Calmette-Guérin for Indian patients: A plea for urgent action
por: Arora, Amandeep, et al.
Publicado: (2022)